Roumen Milev

Biographic Data

ID7376961
NAMERoumen Milev
GIVEN NAMESRoumen
FAMILY NAMEMilev
SIGNATUREMILEV R
AFFILIATIONSQueen's University
ORCID0000-0001-6884-171X
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS0
WORKS AS AUTHOR10
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Assessing the long-term effects of microbial therapeutics as treatment within psychiatry

    Open AccessCassandra Sgarbossa, Arthi Chinna Meyyappan et al.ARTICLEFrontiers in Psychiatry2026

    Overall, this review highlighted the need for more placebo-controlled studies with larger sample sizes to effectively evaluate the longitudinal potential of microbial therapeutics as treatment for mood-disturbances and psychiatric symptoms. With consideration for the limitations of this field, these results provide evidence that there may be long-term benefits of targeting the gut microbiome as treatment for mood-related disturbances

  • Using electronically delivered therapy and brain imaging to understand OCD pathology

    Open AccessCallum Stephenson, Niloufar Malakouti et al.ARTICLEFrontiers in Psychiatry2023

    This project sheds light on the application of e-CBT as a tool to evaluate the effects of treatment on cortical activation, setting the stage for a larger-scale study. The program showed great promise in feasibility and effectiveness. While there were no significant findings regarding changes in cortical activation, the trends were in agreeance with previous literature, suggesting future work could provide insight into whether e-CBT offers compar…

  • Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders

    Open AccessAnthony L Vaccarino, Sandra E Black et al.ARTICLEFrontiers in Psychiatry2023

    The present study supports the use of the QIDS-SR in MDD and suggest that the QIDS-SR can be also used to screen for depressive symptoms in persons with ND. However, gaps in item targeting were noted that suggests that the QIDS-SR cannot differentiate participants falling within certain severity levels. Future studies would benefit from examination in a more severely depressed ND cohort, including those with diagnosed clinical depression

  • Mental health challenges, treatment experiences, and care needs of post-secondary students

    Open AccessElnaz Moghimi, Callum Stephenson et al.ARTICLEBMC Public Health2023

    Various barriers to care, perceived lack of resources, and low knowledge of available interventions may contribute to compromised mental health in post-secondary students. The survey findings indicate that upstream approaches such as integrating mental health education for students may address the varying needs of this critical population. Therapist-involved online mental health interventions may be a promising solution to address accessibility i…

  • Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data

    Open AccessAnthony L Vaccarino, Derek Beaton et al.ARTICLEFrontiers in Psychiatry2022

    The Ontario Brain Institute's "Brain-CODE" is a large-scale informatics platform designed to support the collection, storage and integration of diverse types of data across several brain disorders as a means to understand underlying causes of brain dysfunction and developing novel approaches to treatment. By providing access to aggregated datasets on participants with and without different brain disorders, Brain-CODE will facilitate analyses both…

  • Covid-19 Pandemic

    Open AccessFelicia Iftene, Roumen Milev et al.ARTICLEFrontiers in Psychiatry2022

    The rate of major depression, distress, and suicidal ideation was higher in Canadians than in the worldwide population (per COMET-G), but the relative risk to develop depression in the presence of a history of mental disorders was lower. Almost 90% of Canadians believed in the real story of COVID source of provenience

  • The Efficacy, Safety, and Tolerability of Probiotics on Depression

    Open AccessCaroline Wallace, Caroline J K Wallace et al.ARTICLEFrontiers in Psychiatry2021

    Background: A growing body of research has shown that consumption of probiotics can improve symptoms associated with mood and anxiety disorders through activity of the gut-brain axis. However, the effects of probiotics have yet to be tested in a clinical sample of treatment-naïve patients diagnosed with Major Depressive Disorder (MDD). The aim of this 8-week, open-label pilot study is to examine changes in depressive symptoms before and after the…

  • Canadian Network for Mood and Anxiety Treatments ( Canmat ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder

    Open AccessLakshmi N Yatham, Sherril H Kennedy et al.ARTICLEBipolar Disorders2018

    The Canadian Network for Mood and Anxiety Treatments ( CANMAT ) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar Disorders ( ISBD ). These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since th…

  • Response of Depression to Botulinum Toxin Treatment

    Open AccessRoumen MilevARTICLEFrontiers in Psychiatry2015

    FRONTIERS COMMENTARY article Front. Psychiatry, 20 April 2015 https://doi.org/10.3389/fpsyt.2015.00055

  • Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression

    Open AccessLaura Gedge, Ashley Beaudoin et al.ARTICLEFrontiers in Psychiatry2012

    This study suggests that ECT and rTMS may not exert their clinical effects by altering serum BDNF levels in patients with drug-resistant MDD. Serum BDNF concentration may not be a biomarker of ECT or rTMS treatment response